Arlo Technologies, Inc.: Form 10-Q for the period ended Jul 2, 2023
Filed with the SEC on Aug 10, 2023 and accepted by EDGAR at Aug 10, 2023, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-03 to 2023-07-02 | $115.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-02 | $226.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2023-04-03 to 2023-07-02 | $73.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-07-02 | $149.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-03 to 2023-07-02 | $41.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-02 | $77.1m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-03 to 2023-07-02 | $17.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-07-02 | $35.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-03 to 2023-07-02 | −$8.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-02 | −$22.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-03 to 2023-07-02 | $221.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-02 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-03 to 2023-07-02 | −$7.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-02 | −$21.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-03 to 2023-07-02 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-02 | −$0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-03 to 2023-07-02 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-02 | −$0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-03 to 2023-07-02 | 92,337,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-02 | 90,984,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-02 | $22.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-02 | $2.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-07-02 | $62.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-02 | $232.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-02 | $269.0m | us-gaap:Assets |
| Current liabilities | At period end2023-07-02 | $167.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-02 | $187.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-02 | $81.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001736946-23-000035. Last ingested by Listed: Nov 5, 2026, 18:15 ET. Listed shows no prices and gives no investment advice.